From September 25, 2010 to September 27, 2010

This meeting is organized by the ATTACK research consortium, a large European research project covering 17 Centres. The focus is on genetically engineering T cells to target malignant disease (full details are on our website <www.attack-cancer.org>). The 2010 symposium will cover a multifaceted range of basic science, preclinical and clinical aspects including, but not limited to, T cell homeostasis and differentiation, tumor environment, cytokines, immune responsiveness, gene transfer and cell production.